Orphanet: MATRix : High dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS lymphoma randomized phase III trial
x

Search for a networks

* (*) mandatory field

MATRix: High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS lymphoma - randomized phase III trial

  • Type of network : Multinational clinical trials
  • Funded by an IRDiRC member
  • Geographic coverage : European
  • Funding body(ies) : BMBF, UNIVERSITÄTSKLINIKUM FREIBURG, INFORMATION NOT PROVIDED 
  • Sponsor : -
  • Website
  • Sponsor of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • Universitätsklinikum Freiburg
  • Hugstetter Str. 55
  • 79106 FREIBURG
  • GERMANY
  • More information
  • Phone  : 49 (0)761 270 0
  • Fax  : 49 (0)761 270 20200
  • Website
  • Contact secretary  :
  • Public funding body

  • BMBF
  • Bundesministerium für Bildung und Forschung
  • Hannoversche Straße 28-30
  • 10115 BERLIN
  • GERMANY
  • More information
  • Phone  : 49 (0)1888 57 0
  • Fax  : 49 (0)1888 57 83601
  • Website
Last update: March 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.